title: Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome.
abstract: The renal Fanconi syndrome is a defect of proximal tubular function causing aminoaciduria and low-molecular-weight proteinuria. Dent's disease and Lowe syndrome are defined X-linked forms of Fanconi syndrome; there is also an autosomal dominant idiopathic form (ADIF), phenotypically similar to Dent's disease though its gene defect is still unknown. To assess whether their respective gene products are ultimately involved in a common reabsorptive pathway for proteins and low-molecular-mass endogenous metabolites, we compared renal Fanconi urinary proteomes and metabonomes with normal (control) urine using mass spectrometry and (1)H-NMR spectroscopy, respectively. Urine from patients with low-molecular-weight proteinuria secondary to ifosfamide treatment (tubular proteinuria; TP) was also analyzed for comparison. All four of the disorders studied had characteristic proteomic and metabonomic profiles. Uromodulin was the most abundant protein in normal urine, whereas Fanconi urine was dominated by albumin. (1)H-NMR spectroscopic data showed differences in the metabolic profiles of Fanconi urine vs. normal urine, due mainly to aminoaciduria. There were differences in the urinary metabolite and protein compositions between the three genetic forms of Fanconi syndrome: cluster analysis grouped the Lowe and Dent's urinary proteomes and metabonomes together, whereas ADIF and TP clustered together separately. Our findings demonstrate a distinctive "polypeptide and metabolite fingerprint" that can characterize the renal Fanconi syndrome; they also suggest that more subtle and cause-specific differences may exist between the different forms of Fanconi syndrome that might provide novel insights into the underlying mechanisms and cellular pathways affected.
authors.affiliation: Second University of Naples, Italy.
authors.forename: Annalisa
authors.initials: A
authors.lastname: Vilasi
authors.forename: Pedro R
authors.initials: PR
authors.lastname: Cutillas
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Maher
authors.forename: Severine F M
authors.initials: SF
authors.lastname: Zirah
authors.forename: Giovambattista
authors.initials: G
authors.lastname: Capasso
authors.forename: Anthony W G
authors.initials: AW
authors.lastname: Norden
authors.forename: Elaine
authors.initials: E
authors.lastname: Holmes
authors.forename: Jeremy K
authors.initials: JK
authors.lastname: Nicholson
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Unwin
mesh_terms: D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects; D018118:Chloride Channels / Q000235:genetics / Q000378:metabolism; D016172:DNA Fingerprinting; D005198:Fanconi Syndrome / Q000235:genetics* / Q000378:metabolism* / Q000652:urine; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008660:Metabolism / Q000502:physiology*; D015999:Multivariate Analysis; D009800:Oculocerebrorenal Syndrome / Q000235:genetics / Q000378:metabolism / Q000652:urine; D010455:Peptides / Q000737:chemistry / Q000652:urine; D011507:Proteinuria / Q000378:metabolism; D040901:Proteomics / Q000379:methods*; D021241:Spectrometry, Mass, Electrospray Ionization; D014357:Trypsin / Q000737:chemistry
chemical_list: D018906:Antineoplastic Agents, Alkylating; C097503:CLC-5 chloride channel; D018118:Chloride Channels; D010455:Peptides; D014357:Trypsin; D007069:Ifosfamide